Combined evaluation of the FAS cell surface death receptor and CD8+tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer

Author(s):
Blok, E.J.; Bulk, J. van den; Dekker-Ensink, N.G.; Derr, R.; Kanters, C.; Bastiaannet, E.; Kroep, J.R.; Velde, C.J.H. van de; Kuppen, P.J.K. (0000-0002-0294-3251)
Published
2017
Publication type
Article / Letter to editor
FASbiomarkertumor infiltrating lymphocytesCD8breast cancer
Date issued
2017-02-28
Language
English
Is part of
Oncotarget (2017), Vol. 8, no. 9, p. 15610-15620
hdl
1887/114939
doi
10.18632/oncotarget.14779